Home -> Law Blog Directory -> Patent Law Blogs -> IPBiz
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: IPBizFlashback on peer review
By Lawrence B. Ebert, Esq.
Although written BEFORE the frauds of Jan-Hendrik Schon and Hwang Woo Suk in the journal Science, Smith observed:
Peer review is at the heart of the scientific process yet was until recently largely unexamined. Now we begin to have a body of evidence on peer review (www.wame.org), and it illustrates many defects. Peer review is slow, expensive, profligate of academic time, highly subjective, prone to bias, easily abused, poor at detecting gross defects, and almost useless for detecting fraud. Smith of course was right, and was certainly proved right by Schon and Hwang.
Smith's article was written after the classic idea theft from the Chu paper on superconductors, and after the 1995 Law & Order episode "Big Bang," and observed:
Finally, openness should eliminate some of the worst abuses of peer review, where reviewers?under the cloak of anonymity?steal ideas or procrastinate.
As to "peer review" of patent applications, a patent applicant is nominally protected from idea theft (it is a patent application), BUT a competitor-reviewer may have a conflict-of-interest in not wanting the patent granted. Idea theft is one thing, and depriving someone else of proper credit/reward is a different thing.
On the flip side, the reviewer's analysis may be influenced by fear of reprisal. Smith wrote:
The main argument against open peer review?a sad one?is that junior reviewers will be reluctant to criticise the work of senior researchers for fear of reprisals.
Full post as published by IPBiz on November 04, 2008 (boomark / email).
FDA Issues Update on Safety Review Orlistat
Orlistat FDA Issues Update on Safety Review
Aurora Loan Faces Class Action over Mortgage Review Services
Aurora Loan Faces Class Action over Mortgage Review Services
FDA Review of Prostate Cancer Treatment Prompts Warning of Risk for Diabetes
Prostate Cancer Treatment FDA Review Prompts Warning of Risk for Diabetes
Xigris
Study Prompts FDA Safety Review
Lipitor
Review of Studies Show No Significant Benefit in Women
Wrinkle-Fillers
FDA to Review Labeling due to Adverse Event Reports

Academic Peer Review: Anonymous Blog Commenting v. Traditional Peer Review
From the Judge-said-what files..........
South Carolina Tries Peer Review
Peer Review at the South Carolina Law Review









